Target type: biologicalprocess
Any process that modulates the frequency, rate or extent of the directed movement of lipids within cells. [GOC:mah]
Intracellular lipid transport is a complex and highly regulated process that ensures the efficient delivery of lipids, such as fatty acids, cholesterol, and triglycerides, to various cellular compartments. This intricate process involves a network of proteins, enzymes, and organelles that work in concert to maintain cellular lipid homeostasis. The regulation of intracellular lipid transport is crucial for various cellular functions, including membrane synthesis, energy production, and signal transduction.
**1. Lipid Uptake:**
The journey of intracellular lipid transport begins with the uptake of lipids from the extracellular environment. Cells utilize various mechanisms to acquire lipids, including:
- **Lipoprotein uptake:** Lipoproteins, such as low-density lipoprotein (LDL) and high-density lipoprotein (HDL), transport lipids in the bloodstream. Cells take up these lipoproteins through receptor-mediated endocytosis. For example, LDL binds to LDL receptors on the cell surface, leading to the formation of coated pits that invaginate and internalize LDL.
- **Free fatty acid uptake:** Free fatty acids (FFAs) can directly diffuse across the cell membrane or be transported by specific fatty acid transporters.
**2. Lipid Storage and Mobilization:**
Once internalized, lipids can be stored or mobilized for various cellular needs.
- **Lipid storage:** Triglycerides, the major storage form of lipids, are packaged into lipid droplets (LDs). LDs are dynamic organelles that can expand or shrink depending on cellular lipid levels. They serve as a reservoir for energy and provide building blocks for membrane synthesis.
- **Lipid mobilization:** When cells require energy or building blocks for membrane synthesis, triglycerides are hydrolyzed by lipases into FFAs and glycerol. These mobilized lipids can then be used for energy production or transported to other cellular compartments.
**3. Lipid Trafficking:**
The movement of lipids within the cell is facilitated by a complex network of transport proteins and organelles.
- **Vesicular transport:** Lipids are transported in membrane-bound vesicles, such as lipoprotein particles, endosomes, and lysosomes. Vesicular transport is driven by motor proteins and cytoskeletal elements, which move vesicles along specific tracks within the cell.
- **Protein-mediated transport:** Specific transport proteins, such as fatty acid-binding proteins (FABPs) and sterol carrier proteins (SCPs), bind to lipids and facilitate their movement across cellular membranes.
**4. Lipid Metabolism and Utilization:**
Once transported to their destination, lipids undergo various metabolic processes, including:
- **Fatty acid oxidation:** FFAs are broken down in the mitochondria to generate ATP, the cell's energy currency.
- **Cholesterol synthesis:** Cholesterol is synthesized in the liver and is essential for membrane integrity and steroid hormone production.
- **Lipid biosynthesis:** Cells can synthesize various lipids, including triglycerides, phospholipids, and sterols, from precursor molecules.
**5. Lipid Homeostasis:**
The regulation of intracellular lipid transport is tightly controlled to maintain lipid homeostasis. This involves a complex interplay of:
- **Transcriptional regulation:** Transcription factors control the expression of genes involved in lipid metabolism and transport.
- **Post-translational modifications:** Proteins involved in lipid transport can be modified by phosphorylation, acetylation, or ubiquitination, which can alter their activity and localization.
- **Hormonal regulation:** Hormones, such as insulin and glucagon, regulate lipid metabolism and transport.
**6. Dysregulation of Lipid Transport and Disease:**
Disruptions in intracellular lipid transport can contribute to various diseases, including:
- **Atherosclerosis:** Accumulation of lipids in the arteries leads to plaque formation and cardiovascular disease.
- **Obesity:** Excessive lipid storage in adipose tissue contributes to weight gain and metabolic disorders.
- **Cancer:** Altered lipid metabolism and transport can promote tumor growth and metastasis.
In summary, the regulation of intracellular lipid transport is a vital cellular process that ensures the proper delivery of lipids to different compartments, maintaining cellular function and homeostasis. Dysregulation of this intricate process can lead to various disease states.'
"
Protein | Definition | Taxonomy |
---|---|---|
Sigma intracellular receptor 2 | A sigma intracellular receptor 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q5BJF2] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
astemizole | astemizole : A piperidine compound having a 2-(4-methoxyphenyl)ethyl group at the 1-position and an N-[(4-fluorobenzyl)benzimidazol-2-yl]amino group at the 4-position. Astemizole: Antihistamine drug now withdrawn from the market in many countries because of rare but potentially fatal side effects. | benzimidazoles; piperidines | anti-allergic agent; anticoronaviral agent; H1-receptor antagonist |
carbetapentane | carbetapentane: RN given refers to parent cpd | benzenes | |
chloroquine | chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis. Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses. | aminoquinoline; organochlorine compound; secondary amino compound; tertiary amino compound | anticoronaviral agent; antimalarial; antirheumatic drug; autophagy inhibitor; dermatologic drug |
haloperidol | haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety. Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) | aromatic ketone; hydroxypiperidine; monochlorobenzenes; organofluorine compound; tertiary alcohol | antidyskinesia agent; antiemetic; dopaminergic antagonist; first generation antipsychotic; serotonergic antagonist |
hydroxychloroquine | hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions. Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970) | aminoquinoline; organochlorine compound; primary alcohol; secondary amino compound; tertiary amino compound | anticoronaviral agent; antimalarial; antirheumatic drug; dermatologic drug |
moclobemide | moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression. Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties. | benzamides; monochlorobenzenes; morpholines | antidepressant; environmental contaminant; xenobiotic |
nemonapride | N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide : A benzamide obtained by formal condensation of the carboxy group of 5-chloro-2-methoxy-4-(methylamino)benzoic acid with the amino group of 1-benzyl-2-methylpyrrolidin-3-amine. | benzamides; monochlorobenzenes; monomethoxybenzene; N-alkylpyrrolidine; secondary amino compound; secondary carboxamide; substituted aniline | |
1,3-ditolylguanidine | 1,3-ditolylguanidine: structure given in first source; a selective ligand for the sigma binding sites in the brain | toluenes | |
4-toluic acid | 4-toluic acid: RN given refers to parent cpd; structure p-toluic acid : A methylbenzoic acid in which the methyl substituent is located at position 4. | methylbenzoic acid | |
methyl-4-tyramine | methyl-4-tyramine: found in barley malt; RN given refers to parent cpd; structure given in first source | tyramines | mouse metabolite |
azaperone | azaperone : An N-arylpiperazine that is 2-(piperazin-1-yl)pyridine in which the amino hydrogen is replaced by a 3-(4-fluobenzoyl)propyl group. Used mainly as a tranquiliser for pigs and elephants. Azaperone: A butyrophenone used in the treatment of PSYCHOSES. | aminopyridine; aromatic ketone; monofluorobenzenes; N-alkylpiperazine; N-arylpiperazine; tertiary amino compound | antipsychotic agent; dopaminergic antagonist |
clemastine | clemastine : 2-[(2R)-1-Methylpyrrolidin-2-yl]ethanol in which the hydrogen of the hydroxy group is substituted by a 1-(4-chlorophenyl)-1-phenylethyl group (R configuration). An antihistamine with antimuscarinic and moderate sedative properties, it is used as its fumarate salt for the symptomatic relief of allergic conditions such as rhinitis, urticaria, conjunctivitis and in pruritic (severe itching) skin conditions. Clemastine: A histamine H1 antagonist used as the hydrogen fumarate in hay fever, rhinitis, allergic skin conditions, and pruritus. It causes drowsiness. | monochlorobenzenes; N-alkylpyrrolidine | anti-allergic agent; antipruritic drug; H1-receptor antagonist; muscarinic antagonist |
befol | |||
adenosine-5'-carboxylic acid | purine nucleoside | ||
pentazocine | Pentazocine: The first mixed agonist-antagonist analgesic to be marketed. It is an agonist at the kappa and sigma opioid receptors and has a weak antagonist action at the mu receptor. (From AMA Drug Evaluations Annual, 1991, p97) | benzazocine | |
cannabidiol | cannabidiol : An cannabinoid that is cyclohexene which is substituted by a methyl group at position 1, a 2,6-dihydroxy-4-pentylphenyl group at position 3, and a prop-1-en-2-yl group at position 4. Cannabidiol: Compound isolated from Cannabis sativa extract. | olefinic compound; phytocannabinoid; resorcinols | antimicrobial agent; plant metabolite |
pd 144418 | |||
lu 28-179 | Lu 28-179: sigma(2) ligand and lysosomotropic agent; structure in first source | ||
n-cyclopropyl adenosine-5'-carboxamide | |||
PB28 | PB28 : A member of the class of tetralins that is tetralin that is substituted by 3-(4-cyclohexylpiperazin-1-yl)propyl and methoxy groups at positions 1 and 5, respectively. It is a sigma 2 (sigma2) receptor agonist (Ki = 0.68 nM) and exhibits antineoplastic and anti SARS-CoV-2 activities. | aromatic ether; piperazines; tetralins | anticoronaviral agent; antineoplastic agent; apoptosis inducer; sigma-2 receptor agonist |
pf 04457845 | |||
e-52862 | |||
skepinone-l | skepinone-L: a dibenzosuberone-type p38 MAPK inhibitor; structure in first source | ||
wms 1410 | |||
dolutegravir | difluorobenzene; monocarboxylic acid amide; organic heterotricyclic compound; secondary carboxamide | HIV-1 integrase inhibitor | |
a-1155463 | A-1155463: a Bcl-X(L) inhibitor; structure in first source | ||
MLI-2 | MLI-2 : A member of the class of indazoles that is 1H-indazole that is substituted at position 3 by a 6-(cis-2,6-dimethylmorpholin-4-yl)pyrimidin-4-yl group and at position 5 by a (1-methylcyclopropoxy)group. It is an inhibitor of leucine-rich repeat kinase 2 (LRRK2). | aromatic ether; cyclopropanes; indazoles; morpholines; pyrimidines; tertiary amino compound | EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor |